Hemorrhage as a sign of treatment failure after intra-arterial chemotherapy in retinoblastoma.

Abstract

Intra-arterial melphalan chemotherapy (IAC) continues to demonstrate excellent utility in the treatment of retinoblastoma. We present the case of a 3-month-old boy diagnosed with with unilateral, advanced stage 5B retinoblastoma and a Coats' response in the right eye. After laser therapy he received 3 doses of IAC. Intraretinal hemorrhaging, first noted after the second dose and worsening after the third, preceded complex exudative retinal detachment. With little visual potential and evidence of atropy, the eye was enucleated. This case illustrates that intraretinal hemorrhage may serve as an early predictor of treatment failure.

• Authors: Ruwan A Silva, Sander R Dubovy, Ditte Hess, Rick Stratton, Timothy G Murray
• Journal: Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus (J AAPOS) Vol. 19 Issue 3 Pg. 268-70 (Jun 2015) ISSN: 1528-3933 [Electronic] United States
• PMID: 25907829 (Publication Type: Case Reports, Journal Article)
• Copyright: Copyright © 2015 American Association for Pediatric Ophthalmology and Strabismus. Published by Elsevier Inc. All rights reserved.

Chemical References

• Antineoplastic Agents, Alkylating
• Melphalan

Topics

• Antineoplastic Agents, Alkylating (administration & dosage)
• Eye Enucleation
• Humans
• Infant
• Infusions, Intra-Arterial
• Male
• Melphalan (administration & dosage)
• Neoplasm Seeding
• Neoplasm Staging
• Retinal Detachment (diagnosis)
• Retinal Hemorrhage (diagnosis)
• Retinal Neoplasms (drug therapy, pathology)
• Retinoblastoma (drug therapy, pathology)
• Treatment Failure
• Visual Acuity
• Vitreous Body (pathology)